NYSE
PG
Last Price
US $144.55
KEY FIGURES
MKT CAP
$343.6B
EPS
TTM
$6.62
PEG
TTM
20.61x
P/E
TTM
21.82x
P/S
TTM
4.02x
YIELD
2.97%
GROWTH
Revenue Y/Y
Profit margin
Current Ratio
Capital Returns
31.23%
Return on equity
ROIC: 16.55%
Valuation History
24.5X
Price to Earnings
EV/EBITDA: 17.4X
Cash flow
Profit margin
2.72%
(FY vs FY)
EBITDA Y/Y
0.38%
(FY vs FY)
Cash flow Y/Y
-0.40%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $144.55
-59.82%
Default assumptions
EBITDA Multiple
Fair Value
Market $144.55
-58.09%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
The Procter & Gamble Company cash flow to debt ratio of 50.87% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.
Financial risk - Healthy cash flow growth.
The Procter & Gamble Company's free cash flow has decreased -15.01% from $16.52G last year to $14.04G, signaling decreasing performance
Financial risk - Healthy debt to equity ratio.
The Procter & Gamble Company's debt to equity ratio is 0.64, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial stability - Healthy debt to equity ratio development.
The Procter & Gamble Company's debt has decreased relative to shareholder equity from 0.68 last year to 0.64 today, signaling strengthened financials
Financial stability - Net debt/EBITDA.
The Procter & Gamble Company has a net debt to EBITDA ratio of 1.18x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial stability - ICR.
The Procter & Gamble Company's interest coverage ratio of 22.52 indicates that earnings with good margin can cover interest payments on company debt
Financial risk - Profit margin growth.
The Procter & Gamble Company's profit margin has decreased (-2.72%) in the last year from 18.95% to 18.44%, signaling decreasing performance
Financial risk - Short term assets vs short term liabilities.
The Procter & Gamble Company's short-term liabilities of $38.69G exceed its short-term assets of $26.21G, signaling financial risk
Increasing performance - ROA.
The Procter & Gamble Company's return on assets of 12.68% is higher than the 5.00% threshold, indicating efficient asset utilization
Increasing performance - Absolute return on equity.
The Procter & Gamble Company's return on equity of 29.84%, is higher than 15.00%, indicating good performance
Increasing performance - Earnings quality.
The Procter & Gamble Company's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
The Procter & Gamble Company had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
The Procter & Gamble Company has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
The Procter & Gamble Company has a free cash flow yield of 4.09%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
The Procter & Gamble Company's yearly earnings has increased 0.45% since last year from $15.97G to $16.05G, signaling increasing performance
Increasing performance - Healthy revenue growth.
The Procter & Gamble Company's yearly revenue has increased 3.26% since last year from $84.28G to $87.03G, signaling increasing performance
Increasing performance - ROIC.
ROIC 15.74% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
Increasing performance - 3-year revenue CAGR.
The Procter & Gamble Company's 3-year revenue CAGR of 2.00% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
The Procter & Gamble Company had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
The Procter & Gamble Company had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
The Procter & Gamble Company is overvalued relative to its fair value price of 58.08 based on Discounted Cash Flow model
Undervalued - Earnings yield.
The Procter & Gamble Company has an earnings yield of 4.58%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
Overvalued - EBITDA valuation.
The Procter & Gamble Company is overvalued relative to its fair value price of 60.58 based on EBITDA multiple model
Undervalued - EV/EBITDA.
The Procter & Gamble Company has an EV/EBITDA ratio of 17.35x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Overvalued - PEG ratio value.
The Procter & Gamble Company has a PEG-ratio over 1 which is considered overvalued
Overvalued - P/B ratio.
The Procter & Gamble Company has a price-to-book ratio of 6.45x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value
Undervalued - P/S ratio.
The Procter & Gamble Company has a price-to-sales ratio of 4.02x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue